My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Triaxis, suspension for injection in a pre-filled syringeDiphtheria, Tetanus, Pertussis (acellular component) Vaccine (adsorbed, reduced antigen(s) content)



Sanofi PasteurPA2131/010/002

Main Information

Trade NameTriaxis, suspension for injection in a pre-filled syringeDiphtheria, Tetanus, Pertussis (acellular component) Vaccine (adsorbed, reduced antigen(s) content)
Active SubstancesDiphtheria toxoid
Tetanus toxoid
Pertussis toxoid
Filamentous haemagglutinin
Pertactin (prn)
Fimbriae types 2 and 3
Dosage FormSuspension for injection in pre-filled syringe
Licence HolderSanofi Pasteur
Licence NumberPA2131/010/002

Group Information

ATC CodeJ07AJ Pertussis vaccines
J07AJ52 pertussis, purified antigen, combinations with toxoids

Status

License statusAuthorised
Licence Issued03/06/2016
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print